Fig. 1

Distribution of JAK2 V617F, MPL, and CALR mutations in patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF)
Distribution of JAK2 V617F, MPL, and CALR mutations in patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF)